Results 131 to 140 of about 597,555 (197)
2018 National viral hepatitis progress report [PDF]
The National Viral Hepatitis Progress Report provides information on seven data indicators, providing an objective way to assess progress toward achieving key viral hepatitis goals.Publication date from document properties.NationalProgressReport2018 ...
core
MedComm – Oncology, Volume 5, Issue 3, September 2026.This review highlights mitochondrial DNA (mtDNA) somatic mutations as an emerging and potent endogenous lineage marker, offering distinct advantages over traditional nuclear genomic (nDNA) approaches. Lineage tracing based on mtDNA mutations has matured into an indispensable tool, providing unprecedented insights into tumor biology and holding ...
Zifeng Ruan +4 more
wiley +1 more source
Precision Medical Sciences, Volume 15, Issue 3, Page 164-175, September 2026.Breast cancer subtypes, estrogen receptor‐positive (ER+), HER2‐enriched, and TNBC, are defined by genomic and epigenetic signatures. Multi‐omics profiling, immunotherapy, liquid biopsy, and AI‐driven radiogenomics enable precision medicine. Tools like Oncotype DX and PAM50 support personalized care.
Samina Malik +4 more
wiley +1 more source
Viral hepatitis surveillance United States, 2013 [PDF]
As part of the Centers for Disease Control and Prevention\ue2\u20ac\u2122s (CDC) National Notifiable Diseases Surveillance System (NNDSS), viral hepatitis case-reports are received electronically from state and territorial health departments via CDC\ue2 ...
core
International Journal of Rheumatic Diseases, Volume 29, Issue 9, September 2026.ABSTRACT Aim To compare risks of malignancy, opportunistic infections, and venous thromboembolism between the targeted synthetic disease‐modifying antirheumatic drugs (tsDMARDs) and biologic DMARDs (bDMARDs) at the 2nd and 3rd lines of therapy (LOT). Methods We conducted a cohort study using the National Database of Health Insurance Claims (2013–2021).
Shiori Nishimura +13 more
wiley +1 more source
Viral hepatitis surveillance United States, 2015 [PDF]
The Centers for Disease Control and Prevention\ue2\u20ac\u2122s (CDC) National Notifiable Diseases Surveillance System (NNDSS) (1) receives viral hepatitis case reports electronically each week from state and territorial health departments in the United ...
core
Correction to 'Modelling the evolution of viral oncogenesis'. [PDF]
Philos Trans R Soc Lond B Biol Sci, 2019 Murall CL, Alizon S.
europepmc +1 more source
Cervical Cytokine Profile in High‐Grade Squamous Intraepithelial Lesions
Cytopathology, Volume 37, Issue 5, Page 523-530, September 2026.Hypothetical mechanism of immune modulation in HSIL associated with high‐risk HPV infection, based on observed cytokine suppression. The diagram illustrates impaired Th1 responses, reflected by reduced production of IL‐2 and TNF, which may compromise the activation and cytotoxic function of CD8+ T cells and NK cells, facilitating immune evasion.
Talles Henrique de Araújo Pontes +8 more
wiley +1 more source
Viral hepatitis surveillance United States, 2016 [PDF]
The Centers for Disease Control and Prevention\u2019s (CDC) National Notifiable Diseases Surveillance System (NNDSS) (1) receives viral hepatitis case reports electronically each week from state and territorial health departments in the United States (U ...
core
Dual IRE1 targets: Determinants of the cell fate?
The FEBS Journal, Volume 293, Issue 18, Page 5423-5432, September 2026.IRE1 is an ER stress sensor that restores protein homeostasis through two signaling activities: XBP1s, which upregulates its target gene expression or RIDD which downregulates its target transcripts. We recently identified Dual IRE1 Targets (DIT) which are modulated by both XBP1s and RIDD activities.
Eva Billat +3 more
wiley +1 more source